<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="vaccines-07-00053-t003" orientation="portrait" position="float">
 <object-id pub-id-type="pii">vaccines-07-00053-t003_Table 3</object-id>
 <label>Table 3</label>
 <caption>
  <p>Antibodies undergoing clinical trials.</p>
 </caption>
 <table frame="hsides" rules="rows">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antibody</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target/Mechanism of Action</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Phase Status</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">MEDI8852</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">HA stem</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">IIa completed</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">USA</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">MHAA4549A</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">HA stem</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">II completed</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">USA</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">VIS410</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">HA stem</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">II completed</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">USA</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Intravenous hyper-immune immunoglobulin (IVIG)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Antigen specific antibody pool with neutralizing potential</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">III recruiting</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">USA</td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">Ergoferon</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Suppression of non-specific immune activation (by any virus)</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">IV completed</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">Russia</td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CR6261</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">“highly conserved membrane-proximal stem of H1 and H5 viruses’ HA1 and HA2”</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">II completed</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Note: Information was retrieved from the 
    <uri>clinicaltrials.gov</uri>.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
